Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN)
Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN)
Recruiting · NCT06641154 · Registry updated 2025-01-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crigler-Najjar syndrome, Nutritional and Metabolic Diseases, hereditary disease, hereditary hyperbilirubinemia, inborn errors of metabolism, metabolic disease | Recruiting | Phase 1 / Phase 2 | 2025-01-13 | NCT06641154 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alphaviva LLC | Moscow | Russia | 1 |
| Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare | Moscow | Russia | 1 |